Cargando…

Editorial: Advanced Immunization Technologies for Next Generation Vaccines

Detalles Bibliográficos
Autores principales:	Medaglini, Donata, Andersen, Peter, Rappuoli, Rino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218171/ https://www.ncbi.nlm.nih.gov/pubmed/32435250 http://dx.doi.org/10.3389/fimmu.2020.00878

Ejemplares similares

Modulation of Primary Immune Response by Different Vaccine Adjuvants
por: Ciabattini, Annalisa, et al.
Publicado: (2016)

CD4(+) T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines
por: Ciabattini, Annalisa, et al.
Publicado: (2013)

Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2
por: Pettini, Elena, et al.
Publicado: (2022)

Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population
por: Ciabattini, Annalisa, et al.
Publicado: (2020)

Editorial: A Global Perspective on Vaccines: Priorities, Challenges and Online Information
por: Tagliabue, Aldo, et al.
Publicado: (2019)

Transcriptomics of the Vaccine Immune Response: Priming With Adjuvant Modulates Recall Innate Responses After Boosting
por: Santoro, Francesco, et al.
Publicado: (2018)

Editorial: Reverse Vaccinology
por: Moxon, Richard, et al.
Publicado: (2019)

Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease — current advances and challenges
por: Rappuoli, Rino, et al.
Publicado: (2017)

Structure-based antigen design: a strategy for next generation vaccines
por: Dormitzer, Philip R., et al.
Publicado: (2008)

Designing Vaccines for the Twenty-First Century Society
por: Finco, Oretta, et al.
Publicado: (2014)

Characterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes
por: Ciabattini, Annalisa, et al.
Publicado: (2015)

Prime-Boost Strategies in Mucosal Immunization Affect Local IgA Production and the Type of Th Response
por: Fiorino, Fabio, et al.
Publicado: (2013)

Optimized Protocol for the Detection of Multifunctional Epitope-Specific CD4(+) T Cells Combining MHC-II Tetramer and Intracellular Cytokine Staining Technologies
por: Pastore, Gabiria, et al.
Publicado: (2019)

Editorial overview: Vaccines 2020
por: Pulendran, Bali, et al.
Publicado: (2020)

Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
por: Ciabattini, Annalisa, et al.
Publicado: (2018)

Vaccines Against Antimicrobial Resistance
por: Rosini, Roberto, et al.
Publicado: (2020)

Corrigendum: Vaccines Against Antimicrobial Resistance
por: Rosini, Roberto, et al.
Publicado: (2020)

Vaccine Evolution and Its Application to Fight Modern Threats
por: Andreano, Emanuele, et al.
Publicado: (2019)

Comparison of Open-Source Reverse Vaccinology Programs for Bacterial Vaccine Antigen Discovery
por: Dalsass, Mattia, et al.
Publicado: (2019)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine
por: Stein, Markus, et al.
Publicado: (2013)

Role of the Microbiota in the Modulation of Vaccine Immune Responses
por: Ciabattini, Annalisa, et al.
Publicado: (2019)

Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics
por: VanDuijn, Martijn M., et al.
Publicado: (2017)

Editorial: Next generation B cell targeting therapies in autoimmune diseases
por: Li, Rui, et al.
Publicado: (2023)

Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis
por: Fiorino, Fabio, et al.
Publicado: (2017)

Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies
por: Seleman, Michael, et al.
Publicado: (2017)

Editorial: Irradiation technologies for vaccine development
por: Wijewardana, Viskam, et al.
Publicado: (2023)

Editorial: Next-Generation Sequencing of Human Antibody Repertoires for Exploring B-cell Landscape, Antibody Discovery and Vaccine Development
por: Prabakaran, Ponraj, et al.
Publicado: (2020)

Reprogramming viral immune evasion for a rational design of next-generation vaccines for RNA viruses
por: Su, Chia-Ming, et al.
Publicado: (2023)

Next-Generation Vaccines Based on Bacille Calmette–Guérin
por: Nieuwenhuizen, Natalie E., et al.
Publicado: (2018)

Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development
por: Li, Mengling, et al.
Publicado: (2021)

Editorial: Next generation MSC therapy manufacturing, potency and mechanism of action analysis
por: Chinnadurai, Raghavan, et al.
Publicado: (2023)

Changing Priorities in Vaccinology: Antibiotic Resistance Moving to the Top
por: Tagliabue, Aldo, et al.
Publicado: (2018)

The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials
por: Murphy, Robert L., et al.
Publicado: (2022)

Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies
por: Xuan, Zixue, et al.
Publicado: (2023)

Vaccinology – Editorial
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Editorial: Trained Immunity-Based Vaccines
por: Subiza, Jose Luis, et al.
Publicado: (2021)

New-age vaccine adjuvants, their development, and future perspective
por: Verma, Shailendra Kumar, et al.
Publicado: (2023)

Interferon-γ from Brain Leukocytes Enhances Meningitis by Type 4 Streptococcus pneumoniae
por: Pettini, Elena, et al.
Publicado: (2015)

Editorial: Advances in T Cell Therapeutic Vaccines for HIV
por: Macatangay, Bernard J. C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qp7fj3cf0erf0nh3ile7plpj51